We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+3.66%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$9.03B
AUM Growth
+$1.87B
Cap. Flow
+$1.68B
Cap. Flow %
18.63%
Top 10 Hldgs %
13.82%
Holding
1,787
New
329
Increased
1,367
Reduced
42
Closed
46

Sector Composition

Rank Sector Weight
1 Financials 15.42%
2 Healthcare 14.55%
3 Technology 12.09%
4 Consumer Staples 11.44%
5 Industrials 10.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLUU
1726
DELISTED
Glu Mobile Inc.
GLUU
$32K ﹤0.01%
16,530
+6,369
+63% +$13.4K
CETV
1727
DELISTED
Central European Media Enterprises Ltd
CETV
$31K ﹤0.01%
+12,283
New +$30.9K
EGIO
1728
DELISTED
Edgio, Inc. Common Stock
EGIO
$29K ﹤0.01%
+285
New +$24.2K
IMGN
1729
DELISTED
Immunogen Inc
IMGN
$28K ﹤0.01%
13,531
-49,853
-79% -$100K
DRRX
1730
DELISTED
DURECT Corp
DRRX
$27K ﹤0.01%
2,027
-7,886
-80% -$101K
ACGN
1731
DELISTED
Aceragen Inc
ACGN
$25K ﹤0.01%
+123
New +$29.3K
NNA
1732
DELISTED
Navios Maritime Acquisition Corporation
NNA
$22K ﹤0.01%
+864
New +$19.4K
XCO
1733
DELISTED
Exco Resources
XCO
$20K ﹤0.01%
1,499
+577
+63% +$9.27K
OPCH icon
1734
Option Care Health
OPCH
$3.41B
$19K ﹤0.01%
4,516
+1,740
+63% +$13.4K
BPTH
1735
DELISTED
Bio-Path Holdings Inc
BPTH
$19K ﹤0.01%
+4
New +$19.4K
ATHX
1736
DELISTED
Athersys, Inc. Common Stock
ATHX
$19K ﹤0.01%
+489
New +$21.5K
ASXC
1737
DELISTED
Asensus Surgical, Inc.
ASXC
$15K ﹤0.01%
+860
New +$17.6K
TVIA
1738
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
$15K ﹤0.01%
+12,617
New +$22.9K
TOVX icon
1739
Theriva Biologics
TOVX
$11.1M
$12K ﹤0.01%
+2
New +$20.5K
CYTR
1740
DELISTED
CytRx Corp
CYTR
$6K ﹤0.01%
+2,597
New +$7.63K
ADVM
1741
DELISTED
Adverum Biotechnologies
ADVM
-2,834
Closed -$116K
AFMD
1742
DELISTED
Affimed
AFMD
-2,098
Closed -$58K
ARCT icon
1743
Arcturus Therapeutics
ARCT
$172M
-2,483
Closed -$43K
ELDN icon
1744
Eledon Pharmaceuticals
ELDN
$314M
-94
Closed -$23K
IMUX icon
1745
Immunic
IMUX
$207M
-56
Closed -$136K
LIVN icon
1746
LivaNova
LIVN
$4.43B
-3,430
Closed -$206K
LRMR icon
1747
Larimar Therapeutics
LRMR
$384M
-1,624
Closed -$65K
OCUL icon
1748
Ocular Therapeutix
OCUL
$1.96B
-17,423
Closed -$120K
QURE icon
1749
uniQure
QURE
$2.77B
-15,656
Closed -$120K
RCKT icon
1750
Rocket Pharmaceuticals
RCKT
$376M
-4,671
Closed -$177K

Similar funds

ProShare Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, ProShare Advisors held 1,787 positions worth $9.03B, up 26% from $7.16B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

ProShare Advisors deployed $1.68B of net new capital in Q4 2016, opening 329 new positions and adding to 1,367 existing holdings. Its largest new stake was Opko Health: 373,523 shares worth $3.47M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Linear Technology Corp, an estimated $2M trimmed.

  • ProShare Advisors's largest Q4 2016 buy was Opko Health: 373,523 shares worth $3.47M.
  • ProShare Advisors added most to Apple in Q4 2016, an estimated $58.9M increase.
  • ProShare Advisors's biggest Q4 2016 reduction was Linear Technology Corp, cutting an estimated $2M.
  • ProShare Advisors fully exited Post Properties in Q4 2016, selling an estimated $1.06M.
  • ProShare Advisors's ten largest holdings make up 14% of its $9.03B portfolio in Q4 2016.
  • ProShare Advisors opened 329 new positions and closed 46 in Q4 2016.
  • ProShare Advisors's portfolio value rose 26% quarter-over-quarter to $9.03B.

Based on ProShare Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.